Damora Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-38.2M | $-38.2M | — | $982.0K |
| FY2021 | $-52.3M | $-52.5M | $223.0K | $4.5M |
| FY2022 | $-42.9M | $-43.1M | $196.0K | $5.6M |
| FY2023 | $-36.9M | $-36.9M | — | $5.4M |
| FY2024 | $-18.6M | $-18.6M | — | $3.2M |